Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00437151 · ClinicalTrials.gov registry record · Phase 4
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
A Phase 4 study of Acne, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT00437151: Completed Phase 4 study of Acne, sponsored by Galderma R&D.
NCT00437151 is a Phase 4 study of Acne that has completed, run by Galderma R&D. The registered enrollment target is 61 participants, below the 140-participant average among 26 other Acne trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00437151, a Phase 4 study of Acne, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to investigate potential differences in treatment adherence by teenagers among four interventions during treatment for acne.
Conditions Studied
Interventions
- OTHER More frequent than normal office visits
- OTHER Electronic reminders (voice, e-mail, text messages)
- OTHER Parenteral involvement / intervention reminders
- OTHER No intervention or reminders
Study Locations (1)
North Carolina
- Wake Forest School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
What the finished NCT00437151 record still lists
NCT00437151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 140-participant average among 26 other Acne trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 4 interventions - of which More frequent than normal office visits is the first listed.
NCT00437151 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00437151 about?
NCT00437151 is a clinical study titled "Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%". The primary objective of this study is to investigate potential differences in treatment adherence by teenagers among four interventions during treatment for acne.
What is the current status of trial NCT00437151?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2006-06. Estimated completion is 2007-06.
What conditions does trial NCT00437151 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT00437151?
The interventions under investigation include: More frequent than normal office visits (OTHER), Electronic reminders (voice, e-mail, text messages) (OTHER), Parenteral involvement / intervention reminders (OTHER), No intervention or reminders (OTHER).
Who is sponsoring clinical trial NCT00437151?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00437151 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00437151's enrollment target sits among peer trials
61 16th of 26 higher than 11 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
ACTIVE NOT RECRUITING · Phase 4
-
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
COMPLETED · Phase 4
-
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
COMPLETED · Phase 4
-
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
COMPLETED · Phase 4
-
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
COMPLETED · Phase 4
-
Comparison Study of Topical Acne Regimens
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia